Abbott’s Xience V infringes in France
This article was originally published in The Gray Sheet
Executive Summary
French court rules Jan. 4 that Abbott'sXience V everolimus-eluting stent infringes on intellectual property exclusively licensed to Medtronic by privately-held Vancouver, B.C. firm evYsio Medical Devices. The ruling places an injunction on Xience V sales in France, according to evYsio, but Abbott has not yet launched the product in that country. The French case is the first to yield a verdict among a string of suits filed by Medtronic and evYsio in Europe and the United States in 2006 involving a design patent relating to a stent's ability to maintain flexibility and deliverability without compromising strength, according to Medtronic...